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Candida albicans is a human opportunist pathogen that can grow as yeast, pseudo-
hyphae, or true hyphae in  vitro and in  vivo, depending on environmental conditions. 
Reversible cellular morphogenesis is an important virulence factor that facilitates invasion 
of host tissues, escape from phagocytes, and dissemination in the blood stream. The 
innate immune system is the first line of defense against C. albicans infections and is 
influenced by recognition of wall components that vary in composition in different mor-
phological forms. However, the relationship between cellular morphogenesis and immune 
recognition of this fungus is not fully understood. We therefore studied various vegetative 
cell types of C. albicans, singly and in combination, to assess the consequences of 
cellular morphogenesis on selected immune cytokine outputs from human monocytes. 
Hyphae stimulated proportionally lower levels of certain cytokines from monocytes 
per unit of cell surface area than yeast cells, but did not suppress cytokine response 
when copresented with yeast cells. Pseudohyphal cells induced intermediate cytokine 
responses. Yeast monomorphic mutants had elevated cytokine responses under con-
ditions that otherwise supported filamentous growth and mutants of yeast and hyphal 
cells that were defective in cell wall mannosylation or lacking certain hypha-specific cell 
wall proteins could variably unmask or deplete the surface of immunostimulatory ligands. 
These observations underline the critical importance of C. albicans morphology and 
morphology-associated changes in the cell wall composition that affect both immune 
recognition and pathogenesis.
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inTrODUcTiOn
Fungal pathogens are associated with a wide range of human diseases from superficial infections of 
the skin and mucosal surfaces to life-threatening systemic infections, depending on host health and 
immunocompetence. Candida species account collectively for as many as 400,000 cases of systemic 
fungal disease with associated mortality rates of up to 40% (1–4). Of these species, Candida albicans is 
the most common agent of disease and is characterized by its morphological plasticity. It is capable of 
vegetative growth in vitro and in vivo as ovoid budding yeast-like cells and as branching filamentous 
cells that exist as more or less elongated and constricted chains of yeast cells called pseudohyphae 
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or parallel-sided hyphal cells (5–10). Other cell types, such as 
GUT, gray, and opaque cells, are a tristable system of specialized 
cells involved in colonization of specific body sites and in mating 
competence (10). We set out to characterize differences in the 
immune response by human peripheral blood mononuclear cells 
(PBMCs) to yeast cells, hyphae, and pseudohyphae as the three 
major morphological forms of C. albicans.
The innate immune system is the first line of defense against all 
invading organisms and plays a major role in resistance to infec-
tious diseases in immunocompetent hosts (11). Phagocytes detect 
microbial pathogen-associated molecular patterns (PAMPs) via 
pattern-recognition receptors (PRRs), resulting in signaling-
mediated transcription and secretion of inflammatory mediators, 
such as chemokines and cytokines that recruit neutrophils and 
other immune cells to the site of infection, resulting in localized 
killing of the pathogen and activation of the adaptive immune 
response (11–13).
C. albicans PAMPs that activate the inflammatory response 
are located in both the outer and inner layers of the intact cell 
wall (4, 11, 14–16). Mannans and glucans are the main elicitors of 
both cytokine production and phagocytosis and are recognized 
by a range of C-type lectins and toll-like receptors (TLRs) (4, 
17–21). The O-linked mannans are sensed through the TLR4 
receptor (17), β-mannan is recognized by galectin-3 (22–25), 
and α-linked N-mannans are recognized by the mannose recep-
tor (MR), dectin-2, mincle, and DC-SIGN (21, 26). Opsonized 
β1,6-glucan acts as an immune agonist (27), and chitin is taken 
up by the MR and induces TLR9- and NOD2-dependent IL-10 
production (4, 28).
Most immune recognition studies have focused on C. albicans 
yeast cells as the cell target; however, it is known that filamentous 
hyphal cells induce an altered immune response (4, 6, 8, 21, 
29–32). The switch between yeast and hyphal growth is critical 
for virulence (6, 8, 33, 34), affecting numerous properties includ-
ing the expression of morphology-dependent cell wall adhesins, 
invasins, proteases, and a raft of other phenotypic and biochemi-
cal properties, including the recently discovered candidalysin 
toxin (35). Mutants locked in either the yeast or hypha form are 
avirulent, suggesting that the ability to transit reversibly between 
these morphotypes potentiate the virulence of this fungus (7, 33, 
35–40). Pseudohyphae are a distinct growth form that differs 
from both yeast cells and parallel-sided hyphae and are character-
ized by synchronously dividing elongated yeast cells (5, 7, 41, 42). 
Although pseudohyphal forms are generated by a wide range of 
Candida species, we know little about the immune response to 
pseudohyphal cells.
It is therefore important to understand the consequences of 
cellular morphogenesis of C. albicans on immune recognition 
and the activation of inflammation. Here, we demonstrate that 
C. albicans hyphae stimulated lower levels of cytokine production 
from human PBMCs than did yeast cells, but did not suppress 
the immune response of yeast cells in trans. Pseudohyphae 
elicited intermediate cytokine profiles between those of yeast 
and hyphae and again did not suppress yeast-induced cytokines. 
We also demonstrate that cell wall mannosylation and certain 
hypha-specific cell wall proteins affect morphology-dependent 
recognition by PBMCs.
MaTerials anD MeThODs
strains, Media, and culture conditions 
inducing cellular Morphogenesis
Strains used in this work are listed in Table S1 in Supplementary 
Material. Cells were maintained and propagated at 30°C in 
either Sabouraud broth [1% (w/v) mycological peptone, 4% 
(w/v) glucose] or YPD broth [1% (w/v) yeast extract, 2% (w/v) 
mycological peptone, 2% (w/v) glucose]. The immune reposes to 
hyphae induced by multiple independent growth conditions were 
compared. Hyphae were generated using multiple independent 
methods: (i) 20% (v/v) fetal calf serum (FCS) or in RPMI 1640 sup-
plemented with 2.5% (v/v) FCS, (ii) in YPD broth supplemented 
with 20% (v/v) FCS, (iii) in SC broth [0.68% (w/v) yeast nitrogen 
base without amino acids, 0.074% (w/v) amino acids buffered 
with 0.378% (w/v) PIPES] supplemented with 0.012% (w/v) fresh 
N-acetylglucosamine (GlcNAc), or (iv) in Lee’s medium (43). 
Cultures were collected for use when greater 90–95% filamenta-
tion was obtained (typically after 3.5 h of incubation at 37°C). 
Hyphae were then washed twice in PBS and stored frozen at 
−20°C until used in cytokine induction experiments.
C. albicans pseudohyphae were produced using conditions 
published previously with modifications (41). Overnight cultures 
of C. albicans were collected by centrifugation, washed twice with 
0.15 M NaCl, resuspended in 0.15 M NaCl, and incubated at room 
temperature for 24 h to induce starvation. After 24-h starvation, 
cells were inoculated into RPMI 1640 at a final concentration of 
1 × 106 cells/ml and incubated at 25, 30, or 37°C with shaking for 
6 h. Under these conditions, the vegetative morphology could be 
regulated by growth temperature alone, with yeast cells formed 
at 25°C, pseudohyphae at 30°C, and true hyphae at 37°C. Heat-
killed (HK) cells were prepared after incubation at 56°C for 1 h, 
with killing verified by plating on YPD.
Samples of cells were fixed in 5% (v/v) formalin for morpho-
logical and microscopical analyses. All photomicrographs were 
taken on an Olympus BX50 outfitted with an Infinity 1 digital 
camera. Morphology indices, which are a measure of the extent 
of cellular elongation and hence discrimination of constricted 
pseudohyphae from parallel-sided hyphae, were determined as 
published (41). All measurements were made using the measure-
ment tool in ImageJ 1.47v (http://imagej.nih.gov/ij), and MIs 
were calculated in Microsoft Excel.
calculation of the surface area (sa)  
of Fungal cells
The SA of all cells was based on microscopical measurements made 
from DIC images using a Zeiss Axioplan 2 microscope and captured 
by a Hamamatsu C4742-95 digital camera (Hamamatsu Photonics, 
Hamamatsu, Japan). All measurements created by ImageJ were 
exported in Microsoft Excel. The SA of yeast cells was calculated 
based on measurements of the radius calculated from the average 
of the largest and smallest cell diameters of yeast cells (4πr2). Germ 
tube SA was taken as the SA of the mother yeast plus the SA of 
the daughter germ tube (true hypha). Hypha SA based on SA 
(2πr2 + 2πrl) where the germ tube length (l) was measured from the 
base of the mother cell and the germ tube diameter was the average 
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of the narrowest and widest diameter measurements made along 
each germ tube. At least 50 measurements, and 3–4 biological rep-
licates, of SA of individual yeast and hyphal cells grown were made.
cytokine stimulation assays
Blood samples were collected from healthy volunteers accord-
ing to local guidelines and regulations, as approved by the 
College Ethics Review Board of the University of Aberdeen 
(CERB/2012/11/676). The PBMCs were used in this study and 
isolated using Ficoll-Paque™ PLUS (GE Healthcare) as previously 
described (44), with slight modifications. Unless otherwise indi-
cated, 5 × 105 PBMCs in 100 µl were incubated in a round-bottom 
96-well plate (Nunc) with 100 µl of fungal cells at 1 × 106 cells/
ml. After incubation for 24 h at 37°C under 5% (v/v) CO2, plates 
were centrifuged at 1,000 g for 10 min at room temperature, and 
supernatants were saved and kept at −20°C until use. For cytokine 
assays using mixed C. albicans cell types, PBMCs were first pre-
incubated with 50 µl of cells of one morphology at 2 × 106 cells/
ml for 1 h at 37°C under 5% (v/v) CO2. Subsequently, 50 µl of a 
sample containing a second sample of yeast or hyphae cells at 
2 × 106 cells/ml were added to PBMCs. Plates were then incubated 
for a further 24 h at 37°C, before supernatant collection and assay 
of induced cytokines. In experiments with PBMCs, the inoculum 
of hyphal cells was more or less aggregated. To assess the effect of 
cell aggregates on the cytokine stimulation, control experiments 
where hyphae were dispersed by ultrasonication before interac-
tion with immune cells were performed, but theses did not show 
any significant differences with cultures of non-sonicated cells 
(data not shown). Therefore, steric blocking of monocyte access 
to fungal material did not explain the reduced response to hyphae 
that was observed.
TNFα, IL-1α, IL-1β, IL-6, and IL-10 concentrations were 
determined from coculture supernatants. For IL-1α quantifica-
tion, stimulated PBMCs were disrupted by three sequential 
temperature shock cycles, and homogenates used for cytokine 
determination. All cytokine concentrations were determined 
using enzyme-linked immunosorbent assays (R&D Systems) 
according to the manufacturer’s instructions.
cell Wall extraction and analysis
C. albicans cells of different morphology were prepared as 
described above. Cells were collected by low-speed centrifugation 
and washed with ultrapure water, then broken using glass beads 
and a FastPrep machine (Qbiogene), homogenates were centri-
fuged at 13,000 g for 3 min, and pellets, containing the cell debris 
and walls, were washed five times with 1 M NaCl, resuspended 
in cell wall extraction buffer [50 mM Tris–HCl buffer pH 7.5, 2% 
(w/v) SDS, 0.3 M β-mercaptoethanol, and 1 mM EDTA], then 
boiled for 10 min, and washed three times with ultrapure water. 
Cell walls were freeze dried and stored at −20°C until used. The 
β-glucan, mannan, and chitin contents of cell wall preparations 
were determined by acid hydrolysis of the polymers and quanti-
fication of glucose, mannose, and glucosamine. Freeze-dried cell 
walls were hydrolyzed with 2 M trifluoroacetic acid as described 
previously (45), and acid hydrolyzates were analyzed by HPAEC-
PAD (high-performance anion-exchange chromatography with 
pulsed amperometric detection) (46).
hPBMc cell Damage assay
Human PBMC damage was assessed by lactate dehydrogenase 
(LDH) released into the supernatant in the culture medium. 
After 24  h stimulation with C. albicans either heat-killed yeast 
(HKY) or HKH over a range of MOIs (Candida cells:hPBMCs) 
from 0.002:1 to 2:1. The LDH release was determined using the 
cytotoxicity detection kit (Roche Applied Science), according to 
the manufacturer’s instructions. As a negative control for LDH 
release, 5 × 105 cells of hPBMCs were incubated with only the 
cell culture medium and incubated at 37°C with 5% CO2 for 24 h. 
For the positive control maximum LDH release, 5 × 105 cells of 
hPBMCs was obtained by treatment with 2% Triton X-100 and 
incubated under the same conditions. The percentage of LDH 
release was calculated relative to the value for 100% cell death.
statistical analyses
The Mann–Whitney U test, t-test, or one-way ANOVA with a 
Dunnett’s post hoc test in an appropriate parameter was used to 
analyze data. Results are presented as means ± SDs or SEMs and 
levels of significance determined at p < 0.05.
resUlTs
Differential cytokine induction by Yeast 
and Filamentous cell Types
We used the cytokine response of human PBMCs as a read 
out to investigate the role of C. albicans morphogenesis on 
immune recognition. The cytokine profile of human PBMCs 
was compared when these immune cells were exposed to yeast 
cells and filamentous forms (true hyphae and pseudohyphae) of 
C. albicans. Yeast, pseudohyphal, and hyphal cells could all be 
induced in vitro using various culture conditions that preferen-
tially stimulated a specific C. albicans cell morphology. Live and 
HK cells of different cell morphologies were also analyzed in our 
study. Across a wide range of conditions, heat killing increased 
the total amount of TNFα and other cytokines induced by yeast 
cells, and to a lesser extent, filamentous cells (Figure 1), suggest-
ing that heat-treatment unmasks cytokine inducing PAMPs due 
to thermal disruption of components of the outer layer of the cell 
wall, thus exposing internal cytokine inductive cell layers to PRRs 
found on the surface of human PBMCs.
Under the conditions employed, more than 99% of yeast cells 
were obtained at 25°C and more than 94% of hyphae with at least 
two cell compartments were generated at 37°C (data not shown). 
Cell for cell, HK yeast cells induced significantly more TNFα 
than hyphal cells (Figure 1A). Germ tubes/hyphae induced less 
TNFα despite the presence of the parent yeast cell, implying that 
hypha formation may suppress TNFα production that would 
be normally associated with the cell surface of HK yeast cells 
(Figures 1A–C and 3).
TNFα production induced by C. albicans was dose dependent 
(Figure 1B). Live yeast cells stimulated lower cytokine production 
compared to HK yeast cells—a difference that was less apparent 
when comparing live and HK true hyphal cells (Figure 1B). Both 
live and HK hyphae stimulated poor TNFα production compared 
to that of HK yeast cells (Figures 1B,C). In addition, LDH activity 
FigUre 1 | TnFα stimulation with Candida albicans yeast and hyphal 
cells by human peripheral blood mononuclear cells (PBMcs). 
(a) Cytokine production by human PBMCs stimulated with yeasts cells (Y) of 
C. albicans NGY152 grown at 25°C (closed circles) or hyphae (H) grown at 
37°C (closed squares) in RPMI 1640 + 2.5% fetal calf serum (FCS). Error 
bars = SEM (n = 3). (B) Dose-dependent stimulation of TNFα production by 
human PBMCs when stimulated with different forms of C. albicans NGY152 
grown in RPMI 1640 + 2.5% FCS. Heat-killed yeasts (HKY), closed circles; 
live yeasts (LY), open circles; HK hyphae (HKH), closed squares; live hyphae 
(LH), open squares. Error bars = SEM (n = 6). In these experiments, a total of 
5 × 105 PBMCs were used in each treatment and so the MOI varied from 
0.0002:1 to 2:1. (c) Cytokine production by human PBMCs stimulated with 
the different morphological forms of C. albicans NGY152. In each treatment, 
an inoculum of 1 × 106 cells/ml was used. Results are means ± SEM (n = 6; 
*p < 0.05).
FigUre 2 | cell surface area (sa) of hyphal forming cells negatively 
correlated with TnFα stimulation. (a) Cell SA and cell size of Candida 
albicans SC5314 yeast (Y) or hyphae (H) grown at either 25 or 37°C for 1.5, 
2.5, 3.5, and 4 h (*p < 0.05). Error bars are SEM (n > 50 individual cells). 
(B) Relationship between TNFα production and extent of cell elongation 
expressed as the ratio of the hyphal cell area and the mother yeast cell area 
for C. albicans SC5314 and NGY152, and Candida dubliniensis CD36.
4
Mukaremera et al. Candida Morphogenesis and Immune Response
Frontiers in Immunology | www.frontiersin.org June 2017 | Volume 8 | Article 629
released into the supernatant was measured after 24 h stimulation 
with C. albicans HKY or HKH. There was no significant differ-
ence between C. albicans stimulated and non-stimulated hPBMCs 
(Figure S1 in Supplementary Material). Therefore, although TNFα 
production by hPBMCs incubated with 1 × 106 cells of HKY was 
significantly reduced, this was not due a loss of viability of hPB-
MCs. Similar results were obtained for a range of other cytokines, 
including IL-1α, IL-1β, IL-6, and IL-10 (Figure 1C).
We next investigated how hypha cell SA correlated with TNFα 
production by human PBMCs. Cell SA and cell size (diameter or 
length) of C. albicans yeast and hyphae were calculated assuming 
yeast cells were elliptical spheres, and germ tubes were parallel-
sided cylinders. The size and SA of yeast plus associated germ 
tubes cells grown at 25 and 37°C are shown in Figure  2A. SA 
and length of hyphae increased by time. Under these conditions 
(at 3.5 h) of growth, yeasts had a mean diameter of 6.6 ± 0.1 μm 
(mean ±  SEM) and mean SA of 136 ±  3.1  μm2, respectively 
(Figure  2A). Hyphae had approximately twofold increased SA 
and were fivefold longer than the yeast cell diameter at the time 
cells were harvested. These values are comparable with those in 
previous reports (47). The average growth rate of hyphae grown 
in RPMI1640 plus 2.5% serum was 9.0 ± 1.1 μm/h. For C. albicans 
strains SC5314, NGY152, and the hypha-forming species Candida 
dubliniensis (strain CD36), there was a negative correlation 
between hypha to yeast cell surface ratio and TNFα production 
by human PBMCs (Figure 2B). Longer hyphae induced progres-
sively less TNFα production per unit of cell surface (data not 
shown). We conclude that hyphae induce less TNFα than yeast 
cells and that the hypha surface may in some way suppress TNFα 
production by the cell wall of the attached parent yeast cell or 
that the yeast cell wall may be modified during the process of 
germ tube formation, so that it becomes less inductive of cytokine 
formation.
hypha Formation and cytokine induction 
by human PBMcs
In order to confirm whether this observation was indeed related 
to cell morphology rather than the growth conditions used to 
FigUre 3 | TnFα production by human peripheral blood mononuclear 
cells stimulated with morphological mutants of Candida albicans 
mutants or other yeast species. (a) C. albicans NGY152 (WT), JKC19 
(cph1Δ), HLC52 (efg1Δ), HLC54 (cph1Δ/efg1Δ), WYZ12.2 (hgc1Δ), and 
Bca2-10 (tup1Δ). Results are means ± SEM (n = 6; *p < 0.05). (B) TNFα 
stimulation by non-hypha-forming species Saccharomyces cerevisiae 
(S288C) and Candida glabrata (ATCC 2001) compared to hypha-forming 
species C. albicans (NGY152) and Candida dubliniensis (CD36) (*p < 0.05). 
Error bars = SEM (n = 9).
FigUre 4 | stimulation of cytokine production by human peripheral blood mononuclear cells (PBMcs) interacting with Candida albicans yeast cells 
and hyphae. Human PBMCs in RPMI 1640 were preincubated 1 h with either C. albicans NGY152 yeast cells or hyphae and then stimulated with a second cell 
type for 24 h. HKY, heat-killed yeast; LH, live hyphae; HKH, heat-killed hyphae (*p < 0.05; n = 12).
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generate yeast and hyphae, we compared the immune response 
of hyphae generated in different growth media. Live and HK 
hyphae generated in either YPD medium supplement with FCS, 
Lee’s medium, minimal medium (SC) added with GlcNAc, or in 
dilute FCS, were universally poorer inducers of TNFα, IL-1α, 
IL-1β, IL-6, and IL-10 (Table S1 in Supplementary Material) than 
yeast cells. Therefore, the reduced ability of C. albicans hyphae to 
stimulate cytokine production was independent of the hyphal-
inducing growth conditions used.
Next, we investigated the TNFα simulation by yeast cells of 
Candida glabrata and Saccharomyces cerevisiae (48), which, 
unlike C. albicans and C. dubliniensis, are not able to form hyphae 
or pseudohyphae. Yeast cells of S. cerevisiae, C. glabrata, and C. 
dubliniensis stimulated comparable levels of TNFα cytokine 
when grown at 25 and 37°C (Figure  3B). C. dubliniensis yeast 
cells induced less TNFα than C. albicans, when grown at 25°C. 
However, as with C. albicans, C. dubliniensis yeast grown at 25°C 
induced more cytokine than hyphae grown at 37°C. Therefore, 
the hyphae of both C. albicans and C. dubliniensis stimulated less 
TNFα than the respective yeast form.
We then assessed the ability of various mutants that regulate 
morphogenesis to stimulate cytokine production. The cph1Δ 
mutant was still able to form hyphae under the experimental 
conditions used (93% hypha production), and these cells did not 
stimulate a high level of TNFα by human PBMCs (Figure 3A). In 
comparison, the efg1Δ mutant mainly produced pseudohyphae 
(more than 90%) and stimulated only about 15% of TNFα of the 
control HK wild-type yeast cells. The cph1Δ/efg1Δ double mutant 
was unable to form hyphae at 37°C and stimulated significantly 
higher amounts of TNFα at 37°C than the hyphal wild-type 
parent (Figure  3A). Another yeast-locked hgc1Δ mutant also 
induced higher levels of TNFα at 37°C, although surprisingly 
this was also reduced at 25°C, indicating that Hgc1 influences 
TNFα stimulation in human PBMCs for both yeast and hyphae. 
By contrast, the pseudohypha-locked tup1Δ mutant stimulated 
a poor cytokine production at both 25 and 37°C (Figure  3A). 
Similar results for TNFα were observed for IL-1α, IL-1β, IL-6, 
and IL-10 (data not shown).
Next, we investigated the apparent ability of the germ tube to 
inhibit the ability of the mother yeast cells to stimulate TNFα 
cytokine production. PBMCs were pretreated with live or HK 
yeast or hyphae for 1 h, then a second stimulus of the same or 
another morphotype was added. PBMCs preincubated with HK 
yeast cells and then stimulated with either live or HK hyphae were 
not compromised in their ability to produce TNFα (Figure 4). 
Reciprocally when HK hyphae were preincubated with PBMCs 
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and then stimulated with HK yeast cells, there was a no significant 
reduction in the cytokine response (Figure 4). When yeast cells 
and hyphae were mixed together in a ratio 1:1, there was a strong 
cytokine production comparable to that elicited with HK yeast 
cells alone. Therefore, germ tubes with an attached parent yeast 
cell did not induce a response that would normally be associated 
with free yeast cells; however, hyphae did not block cytokine 
stimulation by yeast cells presented in trans.
The possibility that C. albicans reduced cytokine production 
by hyphae was due to blocking receptors on immune cells was 
tested by coincubating hyphal cells with various TLR ligands 
including Pam3CSk4, LPS, zymosan, flagellin, and curdlan. 
However, C. albicans hyphae did not block nor reduce TNFα, 
IL-1β, or IL-1α stimulated by these TLRs ligands used (Figure S2 
in Supplementary Material).
cell Wall composition and the immune 
response
The fungal cell wall contains most of the PAMPs recognized 
by the innate immune cells (4, 11). Thus, we next assessed the 
ability of yeast and hyphal cells with specific cell wall defects 
to stimulate cytokine production by human PBMCs. A chs3Δ 
null mutant with a low chitin content at the cell wall (49), and a 
mnn4Δ mutant (50) lacking cell wall mannosylphosphate, were 
unaffected in the PBMC-induced cytokine production, compared 
to wild-type control cells (Figure  5A). A pmr1Δ mutant (51), 
which is deficient in yeast and hyphal cell wall N- and O-linked 
mannan, induced a reduced cytokine response by HK yeast cells, 
but an increased cytokines response from live and HK hyphae. 
This suggests that for yeast cells the lack of mannan reduced the 
overall immune response, while in hyphae the major effect of 
mannan depletion was to reveal subsurface immunostimulatory 
ligands such as β-glucan. In the O-mannosylation mnt1/mnt2Δ 
mutant (52), and the core N-mannan mns1Δ mutant (45) the 
secretion of most cytokines was enhanced or not affected in yeast 
or hyphal cells. IL-1α secretion from monocytes was enhanced 
to the greatest extend in the pmr1Δ, mnt1/mnt2Δ, and mns1Δ 
mutants in both yeast and hyphal cells (Figure 5B).
We compared the cytokine levels produced by a number of 
mutants that lacked hypha-associated cell wall proteins includ-
ing als3Δ (53), hwp1Δ (54), hyr1Δ (55), and ece1Δ (56) with 
those stimulated with wild-type control cells. Only the hwp1Δ 
HK mutant hyphae stimulated a higher cytokine production 
than wild-type control cells (Figure 5C). Unexpectedly, despite 
the hypha-specific expression pattern for HYR1 (55), the 
hyr1Δ mutant yeast cells stimulated a slightly reduced cytokine 
response from human PBMCs compared to wild-type control 
cells (Figure 5C). The hwp1Δ mutant showed no significant dif-
ferences in mannan, glucan, and chitin content of the cell wall, 
when compared to wild-type control cells in both morphologies 
(Table  1), suggesting that this proteins may act in masking 
cytokine stimulating PAMPs in the cell wall. By contrast, yeast 
and hyphal cells of the mns1Δ and pmr1Δ mutants displayed a 
significant reduction in cell wall mannan and increased levels of 
glucan (Table 1). Therefore, cell wall mannosylation and the pres-
ence of Hwp1 were important for the reduced ability of hyphae of 
C. albicans to induce cytokines by human PBMCs.
We also tested the effect of deletion of the yeast-specific gene 
PGA29 on cytokine production by human PBMCs and noted that 
this HK mutant induced less TNFα under conditions of yeast 
growth (Figure S3 in Supplementary Material). The reconstituted 
heterozygous pga29/PGA29 mutant restored the TNFα induction 
to normal levels. Therefore, morphology-specific cell wall pro-
teins of both yeast and hyphae influenced immune recognition.
C. albicans Pseudohyphae stimulate 
intermediate cytokine levels from human 
PBMcs
We then examined the ability of pseudohyphae to induce cytokine 
production. We deployed a method in which changes in tempera-
ture alone could generate yeast cells, pseudohyphae, or hyphae 
(41, 57). When C. albicans NGY152 was grown in RPMI 1640 
medium at a neutral pH and at 30°C for 6 h (Figure 6A), it repro-
ducibly resulted in a largely pseudohyphal population (~90%). For 
this strain, growth at 25°C yielded yeast cells (MI = 0.65 ± 0.06, 
mean ± SEM), 30°C yielded pseudohyphae (MI = 2.34 ± 0.19), 
and 37°C yielded hyphal forms (MI = 8.65 ± 0.73) (Figure 6B).
Next, we investigated cytokine production of human PBMCs 
stimulated with pseudohyphae in comparison to yeast and 
hyphae. In a range of experiments pseudohyphal cell populations 
generated reproducibly intermediate levels of TNFα and other 
cytokines from live and HK cells, although the differences were 
not always significant at p < 0.05 and the level of significance var-
ied depending on whether the average MI of a given population of 
pseudohyphae was sufficiently distinct from that of populations 
of yeast cells or hyphae (Figures 6A–D). There was a statistically 
significant correlation between the level of TNFα and IL-1β 
cytokine from PBMCs and the MI of C. albicans cells inducing 
these cytokines (Figure 6E).
DiscUssiOn
Multiple independent studies have proposed a positive cor-
relation between the formation of C. albicans hyphae and an 
enhanced capacity for tissue invasion, damage, and virulence (6, 
33, 39). However, the significance of C. albicans morphogenesis 
on the innate immune response has not been fully characterized. 
Here, the interaction of yeasts, pseudohyphae, and hyphae of 
this fungus with cells of the human innate immune system was 
investigated using cytokine production by human PBMCs as an 
immunoassay readout. We demonstrate that yeast cells generated 
more inflammatory cytokines from PBMCs than hyphae, and 
that pseudohyphae generated intermediate cytokine levels. These 
differences were observed in independent strains for cells gener-
ated in different growth media. Heat killing of cells has been used 
frequently in immunological studies of C. albicans to prevent 
cells undergoing filamentation in response to serum components 
of cell culture media when exposing Candida to immune cells 
during cytokine induction assays (58, 59). HK cells had enhanced 
immune responses, which has been interpreted as being due to 
heat-induced permeabilization of the cell wall and subsequent 
exposure of the underlying β1,3-glucan layer, which is strongly 
immunogenic (18). Our data support this hypothesis and suggest 
that HK cells generate a greater cytokine signal because more 
FigUre 5 | cytokine production stimulated by cell wall mutants of yeast and hyphal cells. (a) Cytokine production stimulated by human PBMCs with 
LY—live yeast; HKY—heat-killed yeast; LH—live hyphae; HKH—heat-killed hyphae; Candida albicans mnn4Δ and chs3Δ and control strains, NGY152 and CAF2-1. 
(B) Cytokine stimulation with mannosylation defective mutants, pmr1Δ, mnt1Δ/mnt2Δ, and mns1Δ. (c) als3Δ, hwp1Δ, hyr1Δ, and ece1Δ. Results presented as 
mean ± SEM (n = 6), and the asterisks indicate comparison of the wild-type values and the mutant strains (*p < 0.05).
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TaBle 1 | cell wall composition of Candida albicans strains.
strain glucosamine glucose Mannose
Yeast morphology
WT 1.01 ± 0.4 58.31 ± 2.25 40.68 ± 2.19
hwp1Δ 0.77 ± 0.46 52.99 ± 0.77* 46.24 ± 0.34*
mns1Δ 0.91 ± 1.18 88.71 ± 2.34* 10.38 ± 0.96*
pmr1Δ 1.50 ± 2.05 99.55 ± 3.63* 0.50 ± 1.33*
hypha morphology
WT 4.77 ± 0.32# 87.18 ± 1.54# 8.06 ± 0.99#
hwp1Δ 5.63 ± 0.93# 83.68 ± 2.57# 10.68 ± 1.75#
mns1Δ 6.10 ± 1.34# 87.61 ± 1.59 6.29 ± 0.18#
pmr1Δ 1.48 ± 0.74* 97.72 ± 2.01* 0.80 ± 0.68*,#
Means ± SD (n = 3) *p < 0.05 when comparing the mutant strain with the wild-type 
control cells.
#p < 0.05 when comparing hyphae with yeast cells.
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PAMPs can engage collaboratively with PRRs, thus resulting in 
coreceptor amplification of the cytokine response (18, 60–62).
Although the hyphae used in these experiments also had a 
parental yeast cell, the combined cytokine signal due to the hypha 
plus parent yeast cell was significantly less than that expected 
from the yeast cell alone. This may suggest that either the yeast 
cell surface of germ tube matures to become different from that 
of a free yeast cell or that an unknown mechanism operates in 
germ tubes that are able to block cytokine induction due to the 
mother yeast cell. However, if a blocking signal is present, it does 
not operate in “trans” since hyphae added after free yeast cells 
were used to stimulate PBMCs did not interfere with the ensuing 
yeast cell stimulated cytokine response. Interestingly, hyphae of 
C. dubliniensis also stimulated less cytokine from PBMCs than 
yeast cells. The genomes of C. albicans and C. dubliniensis are 95% 
identical, and the cell walls are also thought to be of similar com-
position, although there are notable differences in the cell wall 
proteome (63). These closely related Candida species therefore 
show both common aspects and some differences in the nature 
of the immune response to yeast and hyphal cells.
Different immune cell types respond differently to C. albicans 
yeast and hyphae. For example, C. albicans hyphae induce higher 
levels of TNFα than yeast cells in macrophages (64, 65), while 
yeast and hyphae stimulate comparable levels of IL-8 cytokine by 
human neutrophils (47). It was shown that C. albicans induced 
different cytokine responses from oral and vaginal epithelial 
cells, and that hyphae induced higher cytokine levels than yeast 
cells in both epithelial cell types (32, 66). However, our findings 
reinforce previous studies where C. albicans filaments (hyphae 
and pseudohyphae) were reported to stimulate the production 
of less IL-12, IFN-γ, IL-1β, and IL-12p70 by human PBMCs and 
murine splenic lymphocytes than C. albicans yeast cells (30, 58, 
67–69). It was also previously reported that TLR4-mediated pro-
inflammatory signals were diminished during the germination of 
C. albicans yeast cells into hyphae (30). Supporting this, we show 
that C. albicans cells grown at 37°C have a progressively reduced 
TNFα cytokine response. In addition, it was reported that C. albi-
cans hyphal cell walls also stimulated less chemokines than yeast 
cell walls (68), and it was suggested that this may be due to surface 
expression of β1,6-glucan being lower on hyphae compared to 
yeast cells. The cell SA of each individual hyphal compartment is 
larger than that of a yeast cell, and hyphae have no bud scars where 
inner wall layers are exposed (29). Therefore, it is possible that the 
density of certain immune agonists is less concentrated on the 
hyphal surface than on yeast cells. Also, progressive elongation of 
hyphae in vivo has been shown to result in increasing exposures 
of β1,3-glucan (70). Hence, cellular morphogenesis leading to 
filamentous growth of C. albicans leads to important progressive 
modifications of cell wall composition and architecture that has 
profound and differing effects on the immune response.
Cell wall polysaccharide analysis showed that yeast cell walls 
contained significantly higher amounts of mannan but lower 
amounts chitin and glucan compared to that of hyphal cell walls 
(Table 1). The reduction of mannan and increase in chitin content 
of hyphal cell walls might also be related to the lower cytokine 
responses to C. albicans hyphae (28, 45, 71, 72). Our results 
underline the importance of N- and O-linked mannans in the 
recognition of C. albicans hyphae by human PBMCs (Figure 5) 
since N- and O-mannan mutants (45, 52), but not chitin and 
phosphomannan mutants, stimulated the production of higher 
levels of cytokines that wild-type hyphae.
Although the primary polysaccharides in the cell wall are likely 
to have a major influence on immune recognition, it was noted 
that a HK hwp1Δ cell wall protein deletion mutant induced an 
increased cytokine signal, despite having no measurable altera-
tion in hyphal mannan or glucan content. Similarly, a mutant 
lacking MNS1 grown under hyphal-inducing conditions showed 
insignificant changes in cell wall components, but substantial 
reduction in cytokine production. However, the mns1 yeast cells 
had 34% increased glucan as a compensation of 70% reduction in 
mannan, and a reduced cytokine profile. Therefore, there was no 
direct or universal correlation between cytokine induction and 
gross cell wall polysaccharide composition.
Our observations suggest that surface proteins, polysac-
charides, and virulence factors are regulated or modified during 
filamentous growth resulting in changes in the immune response. 
Such changes in the incorporation of surface cell wall proteins 
on cells of different morphology could mask or unmask PAMPs, 
thereby blocking or promoting PRR engagement.
The presence of C. albicans hyphae could potentially compete 
with yeast cells for the ability to bind PRRs and stimulate immune 
cells. This would be important if specific yeast cell wall proteins 
are important for immune recognition and activation. We 
observed that a pga29 mutant grown in the yeast form stimulated 
less TNFα from human PBMCs. This cell wall protein Pga29 has 
homologs in several pathogenic Candida spp. and is abundant 
in yeast cell walls in C. albicans but not in hyphae (73). Deletion 
of PGA29 resulted in decreased glucan–mannan in the cell wall, 
and reduction of TNFα, IL-6, and IL-8 stimulated by oral recon-
stituted human epithelial cells (74). Therefore, both yeast and 
hypha-specific cell wall proteins may directly modulate immune 
responses.
It is also possible that C. albicans hyphal cells may produce 
secreted molecules that suppress immune recognition. Quorum-
sensing molecules, such as farnesol, tyrosol, phenylethanol, 
and tryptophol, produced by C. albicans, play a key role in 
morphogenesis (75–77), and tyrosol acts negatively on cytokine 
production stimulated by RAW 264.7 macrophages induced 
FigUre 6 | cytokine production by hPBMcs stimulated by different Candida albicans morphological forms. (a) Yeasts (i–ii), pseudohyphae (iii–iv), or 
hyphae (v–vi) of C. albicans NGY152 were grown in RPMI 1640 (pH 7) for 6 h at 25, 30, and 37°C, respectively, fixed, and stained with 25 µg/ml CFW to visualize 
the cell wall. Scale bars = 10 µm. (B) Morphological index (MI) of yeast, pseudohyphal, and hyphal cells was measured. Error bars are SEMs (averages from 50 cell 
measurements and 4 biological replicates) (*p < 0.05; **p < 0.01). (c) TNFα cytokine production elicited by human peripheral blood mononuclear cells (PBMCs) with 
HK NGY152 of yeast (Y), pseudohypha (PH), and hypha (H) cells. Each replicate (R1–R4) were averaged as total values. Data are means ± SEM (n > 6; *p < 0.05). 
(D) IL-6, IL-1β, IL-1α, and IL-10 cytokine production elicited by human PBMCs with HK of yeast (Y), pseudohypha (PH), and hypha (H) cells. Data are means ± SEM 
(n > 6; *p < 0.05). (e) Correlation between TNFα or IL-1β cytokine and MI. Results are Person R values (n = 4 biological replica).
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by lipopolysaccharide (78). However, we showed that neither 
live nor HK hyphae could suppress yeast cell-induced cytokine 
production in trans; therefore, soluble factors were not suggested 
as playing a significant role in our experiments.
Our observations and those of previous studies (30, 58, 
68, 69) demonstrate that C. albicans hyphae stimulated lower 
cytokine production by PBMCs than C. albicans yeast cells, 
thus indicating that C. albicans hyphae may help to evade or 
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alter the host immune response. However, it is clear that C. 
albicans hyphae induced strong cytokine responses and caused 
more damage to epithelial cells, while yeast cells did not trigger 
cytokine responses (66, 79, 80). Also, C. albicans hyphae induce 
stronger cytokine responses that yeast cells from macrophages 
(64, 65). The common denominator of these various reports is 
that cellular morphogenesis plays an important role in deter-
mining the immune response to C. albicans, but the nature 
of this response is both host cell type specific and pathogen 
morphotype dependent. These data underline the perspective 
that C. albicans presents a moving target to the cells of the innate 
immune response.
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FigUre s1 | cell damage assay of hPBMc stimulated with Candida 
albicans. Lactate dehydrogenase activity released from 5 × 105 hPBMCs into 
the culture medium was determined after 24 h stimulated with either C. albicans 
heat-killed yeast or HKH at the different number of cells from 1 × 102 to 1 × 106 
cells. The result represented as a percentage relative to 100% cell death of 
hPBMCs when killed with 2% Triton-X-100. Error bars = SEM (n = 4).
FigUre s2 | cytokine production by hPBMcs stimulated by different 
Candida albicans coincubated with toll-like receptors (Tlrs) ligands. 
Human peripheral blood mononuclear cells were stimulated using a mixture of  
C. albicans cells and TLRs ligands. Cells were either live (L) or heat-killed (HK), 
and yeast (Y) or hyphae (H). TLRs ligands used were flagellin (for TLR5), LPS  
(for TLR4), Pam3CSK4 (for TLR2/TLR1), zymosan, and curdlan (for Dectin-1). The 
cytokines measured were TNF-α (a), IL-6 (B), IL-1β (c), IL-1α (D), and IL-10 
(e). IL-10 was barely detectable and could not be evaluated. Data are 
means ± SEM (n > 3; *p < 0.05). ND, not detectable.
FigUre s3 | TnFα cytokine production by hPBMcs incubated with 
Candida albicans lacking PGA29. C. albicans cells lacking PGA29 was grown 
in RPMI 1640 + 2.5% fetal calf serum at 25 or 37°C for 3.5 h. Cells were 
collected and heat killed. The mutant was incubated with hPBMCs for 24 h. 
Then, TNFα cytokine production was determined (see Methods and Materials). 
Data are means ± SEM (n > 9; *p < 0.05; ***p < 0.001).
TaBle s1 | C. albicans and other fungal strains used in this study.
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